{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T01:29:55Z","timestamp":1790386195725,"version":"4.1.0"},"reference-count":58,"publisher":"Frontiers Media SA","content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"DOI":"10.3389\/fphar.2017.00643","type":"journal-article","created":{"date-parts":[[2017,9,12]],"date-time":"2017-09-12T00:44:15Z","timestamp":1505177055000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":40,"title":["Shortened Spadin Analogs Display Better TREK-1 Inhibition, In Vivo Stability and Antidepressant Activity"],"prefix":"10.3389","volume":"8","author":[{"given":"Alaeddine","family":"Djillani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariel","family":"Pietri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9bastien","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Heurteaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Mazella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Borsotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2017,9,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2368","DOI":"10.1038\/sj.emboj.7601116","article-title":"TREK-1, a K+ channel involved in polymodal pain perception","volume":"25","author":"Alloui","year":"2006","journal-title":"EMBO J."},{"key":"B2","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1111\/bph.12953","article-title":"Targeting two-pore domain K+ channels TREK-1 and TASK-3 for the treatment of depression: a new therapeutic concept","volume":"172","author":"Borsotto","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/S0091-3057(00)00271-9","article-title":"Gender differences in learned helplessness behavior are influenced by genetic background","volume":"66","author":"Caldarone","year":"2000","journal-title":"Pharmacol. Biochem. Behav."},{"key":"B4","first-page":"137","article-title":"Two components of delayed rectifier K+ current in heart: molecular basis, functional diversity, and contribution to repolarization","volume":"25","author":"Cheng","year":"2004","journal-title":"Acta Pharmacol. Sin."},{"key":"B5","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1177\/0269881115581093","article-title":"Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 2008 British Association for Psychopharmacology guidelines","volume":"29","author":"Cleare","year":"2015","journal-title":"J. Psychopharmacol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"2525","DOI":"10.1517\/14656566.2014.960842","article-title":"A review of the clinical efficacy, safety and tolerability of the antidepressants vilazodone, levomilnacipran and vortioxetine","volume":"15","author":"Deardorff","year":"2014","journal-title":"Expert Opin. Pharmacother."},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.pbiomolbio.2017.05.005","article-title":"Stretch-activated potassium currents in the heart: focus on TREK-1 and arrhythmias","author":"Decher","year":"2017","journal-title":"Prog. Biophys. Mol. Biol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"2604","DOI":"10.1111\/bph.13083","article-title":"In vitro and in vivo regulation of synaptogenesis by the novel antidepressant spadin","volume":"172","author":"Devader","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1016\/S0893-133X(01)00358-X","article-title":"Regulation of adult neurogenesis by antidepressant treatment","volume":"25","author":"Duman","year":"2001","journal-title":"Neuropsychopharmacology"},{"key":"B10","doi-asserted-by":"publisher","first-page":"22","DOI":"10.4088\/PCC.v03n0105","article-title":"SSRI Antidepressant medications: adverse effects and tolerability","volume":"3","author":"Ferguson","year":"2001","journal-title":"Prim. Care Companion J. Clin. Psychiatry"},{"key":"B11","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1097\/JCP.0b013e3181ee0f5f","article-title":"Antidepressant pharmacotherapy failure and response to subsequent electroconvulsive therapy: a meta-analysis","volume":"30","author":"Heijnen","year":"2010","journal-title":"J. Clin. Psychopharmacol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1038\/nn1749","article-title":"Deletion of TREK-1, a background potassium channel, results in a depression-resistant phenotype","volume":"9","author":"Heurteaux","year":"2006","journal-title":"Nature Neurosci."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1037\/a0038550","article-title":"A brief history of the development of antidepressant drugs: from monoamines to glutamate","volume":"23","author":"Hillhouse","year":"2015","journal-title":"Exp. Clin. Psychopharmacol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"5","DOI":"10.4088\/JCP.11096su1c.01","article-title":"The epidemiology of depression and the evolution of treatment","volume":"73","author":"Hirschfeld","year":"2012","journal-title":"J. Clin. Psychiatry"},{"key":"B15","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/nrn2117","article-title":"The neuronal background K2P channels: focus on TREK1","volume":"8","author":"Honore","year":"2007","journal-title":"Nat. Rev. Neurosci."},{"key":"B16","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1177\/0004867413486842","article-title":"Ketamine as a new treatment for depression: a review of its efficacy and adverse effects","volume":"47","author":"Katalinic","year":"2013","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"B17","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.coph.2014.11.005","article-title":"How does ketamine elicit a rapid antidepressant response?","volume":"20","author":"Kavalali","year":"2015","journal-title":"Curr. Opin. Pharmacol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1002\/mpr.1359","article-title":"Twelve-month and lifetime prevalence and lifetime morbid risk of anxiety and mood disorders in the United States","volume":"21","author":"Kessler","year":"2012","journal-title":"Int. J. Methods Psychiatr. Res."},{"key":"B19","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1007\/s004240100626","article-title":"Localization of TREK-2 K+ channel domains that regulate channel kinetics and sensitivity to pressure, fatty acids and pHi","volume":"442","author":"Kim","year":"2001","journal-title":"Pflugers Arch."},{"key":"B20","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1177\/0269881115609072","article-title":"The serotonergic system in the neurobiology of depression: relevance for novel antidepressants","volume":"30","author":"Kohler","year":"2016","journal-title":"J. Psychopharmacol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1038\/nature07455","article-title":"The molecular neurobiology of depression","volume":"455","author":"Krishnan","year":"2008","journal-title":"Nature"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1038\/nm.2216","article-title":"A dominant-negative mutation in the TRESK potassium channel is linked to familial migraine with aura","volume":"16","author":"Lafreniere","year":"2010","journal-title":"Nat. Med."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1093\/emboj\/19.8.1784","article-title":"Polyunsaturated fatty acids are potent neuroprotectors","volume":"19","author":"Lauritzen","year":"2000","journal-title":"EMBO J."},{"key":"B24","doi-asserted-by":"publisher","first-page":"32068","DOI":"10.1074\/jbc.M302631200","article-title":"K+-dependent cerebellar granule neuron apoptosis. Role of task leak K+ channels","volume":"278","author":"Lauritzen","year":"2003","journal-title":"J. Biol. Chem."},{"key":"B25","first-page":"793","article-title":"Molecular and functional properties of two pore domain potassium channels","volume":"279","author":"Lesage","year":"2000","journal-title":"Am. J. Physiol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.pbb.2015.05.013","article-title":"Reversal of age-associated cognitive deficits is accompanied by increased plasticity-related gene expression after chronic antidepressant administration in middle-aged mice","volume":"135","author":"Li","year":"2015","journal-title":"Pharmacol. Biochem. Behav."},{"key":"B27","doi-asserted-by":"publisher","first-page":"145","DOI":"10.2174\/1381612053382223","article-title":"Increasing hippocampal neurogenesis: a novel mechanism for antidepressant drugs","volume":"11","author":"Malberg","year":"2005","journal-title":"Curr. Pharm. Des."},{"key":"B28","doi-asserted-by":"publisher","first-page":"2030","DOI":"10.1111\/j.1742-1241.2007.01602.x","article-title":"Neurobiology of depression: an integrated view of key findings","volume":"61","author":"Maletic","year":"2007","journal-title":"Int. J. Clin. Pract."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0898-6568(00)00130-3","article-title":"Sortilin\/neurotensin receptor-3: a new tool to investigate neurotensin signaling and cellular trafficking?","volume":"13","author":"Mazella","year":"2001","journal-title":"Cell. Signal."},{"key":"B30","doi-asserted-by":"publisher","first-page":"e1000355","DOI":"10.1371\/journal.pbio.1000355","article-title":"Spadin, a sortilin-derived peptide, targeting rodent TREK-1 channels: a new concept in the antidepressant drug design","volume":"8","author":"Mazella","year":"2010","journal-title":"PLoS Biol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"e25602","DOI":"10.1371\/journal.pone.0025602","article-title":"A human TREK-1\/HEK cell line: a highly efficient screening tool for drug development in neurological diseases","volume":"6","author":"Moha ou Maati","year":"2011","journal-title":"PLoS ONE"},{"key":"B32","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.neuropharm.2011.07.019","article-title":"Spadin as a new antidepressant: absence of TREK-1-related side effects","volume":"62","author":"Moha Ou Maati","year":"2012","journal-title":"Neuropharmacology"},{"key":"B33","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1034\/j.1600-0447.108.s418.15.x","article-title":"Suicide, suicidality and suicide prevention in affective disorders","volume":"418","author":"Moller","year":"2003","journal-title":"Acta Psychiatr. Scand. Suppl."},{"key":"B34","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1093\/emboj\/18.3.595","article-title":"Propeptide cleavage conditions sortilin\/neurotensin receptor-3 for ligand binding","volume":"18","author":"Munck Petersen","year":"1999","journal-title":"EMBO J."},{"key":"B35","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S0896-6273(02)00653-0","article-title":"Neurobiology of depression","volume":"34","author":"Nestler","year":"2002","journal-title":"Neuron"},{"key":"B36","doi-asserted-by":"publisher","first-page":"402","DOI":"10.4161\/chan.5.5.16469","article-title":"Molecular regulations governing TREK and TRAAK channel functions","volume":"5","author":"Noel","year":"2011","journal-title":"Channels"},{"key":"B37","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/S0166-2236(00)01810-5","article-title":"Properties and modulation of mammalian 2P domain K+ channels","volume":"24","author":"Patel","year":"2001","journal-title":"Trends Neurosci."},{"key":"B38","doi-asserted-by":"publisher","first-page":"4283","DOI":"10.1093\/emboj\/17.15.4283","article-title":"A mammalian two pore domain mechano-gated S-like K+ channel","volume":"17","author":"Patel","year":"1998","journal-title":"EMBO J."},{"key":"B39","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1038\/266730a0","article-title":"Depression: a new animal model sensitive to antidepressant treatments","volume":"266","author":"Porsolt","year":"1977","journal-title":"Nature"},{"key":"B40","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1038\/mp.2017.36","article-title":"Identifying fast-onset antidepressants using rodent models","volume":"22","author":"Ramaker","year":"2017","journal-title":"Mol. Psychiatry"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1176\/ajp.2006.163.11.1905","article-title":"Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report","volume":"163","author":"Rush","year":"2006","journal-title":"Am. J. Psychiatry"},{"key":"B42","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1085\/jgp.96.1.195","article-title":"Two components of cardiac delayed rectifier K+ current. Differential sensitivity to block by class III antiarrhythmic agents","volume":"96","author":"Sanguinetti","year":"1990","journal-title":"J. Gen. Physiol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1126\/science.1083328","article-title":"Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants","volume":"301","author":"Santarelli","year":"2003","journal-title":"Science."},{"key":"B44","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1602\/neurorx.2.4.590","article-title":"Innovative approaches for the development of antidepressant drugs: current and future strategies","volume":"2","author":"Schechter","year":"2005","journal-title":"NeuroRx"},{"key":"B45","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/S1537-1891(02)00202-1","article-title":"Drug delivery to brain via the blood-brain barrier","volume":"38","author":"Scherrmann","year":"2002","journal-title":"Vascul. Pharmacol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/j.biopsych.2010.06.009","article-title":"Objective cognitive performance associated with electroconvulsive therapy for depression: a systematic review and meta-analysis","volume":"68","author":"Semkovska","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"B47","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/515180a","article-title":"Mental health: a world of depression","volume":"515","author":"Smith","year":"2014","journal-title":"Nature"},{"key":"B48","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.pharep.2017.01.030","article-title":"Vortioxetine: a review of the pharmacology and clinical profile of the novel antidepressant","volume":"69","author":"Sowa-Kucma","year":"2017","journal-title":"Pharmacol. Rep."},{"key":"B49","doi-asserted-by":"crossref","first-page":"7491","DOI":"10.1523\/JNEUROSCI.21-19-07491.2001","article-title":"Cns distribution of members of the two-pore-domain (KCNK) potassium channel family","volume":"21","author":"Talley","year":"2001","journal-title":"J. Neurosci."},{"key":"B50","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1016\/j.euroneuro.2016.03.007","article-title":"A meta-analysis of randomized, placebo-controlled trials of vortioxetine for the treatment of major depressive disorder in adults","volume":"26","author":"Thase","year":"2016","journal-title":"Eur. Neuropsychopharmacol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1007\/s00213-014-3683-2","article-title":"Retroinverso analogs of spadin display increased antidepressant effects","volume":"232","author":"Veyssiere","year":"2015","journal-title":"Psychopharmacology"},{"key":"B52","doi-asserted-by":"publisher","first-page":"155","DOI":"10.4306\/pi.2015.12.2.155","article-title":"Vilazodone for the treatment of major depressive disorder: focusing on its clinical studies and mechanism of action","volume":"12","author":"Wang","year":"2015","journal-title":"Psychiatry Investig."},{"key":"B53","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1042\/CS20150533","article-title":"Therapeutic targeting of two-pore-domain potassium (K2P) channels in the cardiovascular system","volume":"130","author":"Wiedmann","year":"2016","journal-title":"Clin. Sci."},{"key":"B54","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/35072566","article-title":"Research and treatment approaches to depression","volume":"2","author":"Wong","year":"2001","journal-title":"Nat. Rev. Neurosci."},{"key":"B55","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1038\/nrneurol.2010.166","article-title":"Migraine: familial migraine with aura is associated with a mutation in the TRESK potassium channel","volume":"6","author":"Wood","year":"2010","journal-title":"Nat. Rev. Neurol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1080\/10611860290022679","article-title":"Pharmacokinetics and brain uptake of biotinylated basic fibroblast growth factor conjugated to a blood-brain barrier drug delivery system","volume":"10","author":"Wu","year":"2002","journal-title":"J. Drug Target."},{"key":"B57","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s13041-017-0306-y","article-title":"The role of 5-HT receptors in depression","volume":"10","author":"Yohn","year":"2017","journal-title":"Mol. Brain"},{"key":"B58","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.ejphar.2007.12.005","article-title":"A mouse model of depression induced by repeated corticosterone injections","volume":"581","author":"Zhao","year":"2008","journal-title":"Eur. J. Pharmacol."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fphar.2017.00643\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,3]],"date-time":"2019-10-03T06:27:38Z","timestamp":1570084058000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fphar.2017.00643\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,12]]},"references-count":58,"alternative-id":["10.3389\/fphar.2017.00643"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2017.00643","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,12]]},"article-number":"643"}}